As AI continues to reshape healthcare, physicians are increasingly open to integrating AI-driven tools into their clinical practice. Over the past 2 years, more physicians report being approached by pharma companies with AI-related offerings. However, even as their willingness grows, many physicians say they still have not been approached by pharmaceutical companies offering AI-related resources, revealing a clear gap between physicians’ interest and the pharma support for AI adoption they’re currently receiving.
What’s striking is that physicians’ enthusiasm for partnering with pharma on AI has remained consistently strong over the past 2 years. Their interest has not dipped, but the level of outreach from pharma has yet to match this steady appetite for collaboration. This stability signals a reliable, ongoing opportunity for pharma to step in and support AI adoption more meaningfully. Stronger pharma support for AI adoption remains a missing piece.
The data also highlights a significant gap between physicians’ current use of AI and their willingness to adopt it over the next 5 years. This wide gap represents a major opportunity. Pharma can help bridge it – supporting clinicians in exploring, testing, and scaling AI tools that enhance decision-making, improve efficiency, and ultimately benefit patient care. Pharma support for AI adoption could be the factor that accelerates this shift.
In short, physicians are ready. They’re open. They’re interested. The question now is whether pharma is prepared to meet this moment and help drive the next wave of AI adoption in healthcare, a moment that will require meaningful pharma support for AI adoption.
Infographics may contain select findings from our Independent Studies. Contact us to find out if your organization qualifies for a complimentary presentation with access to the full report.
Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.
